Stock & Company Details
Bright Minds Biosciences Inc $DRUG
Price:
N/A
N/A
9.7M
$546M
52 Week High:
N/A
10 Day Average Volume:
N/A
-16.68
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
DRUG technical indicators
Latest Bright Minds Biosciences Inc (DRUG) indicator readings as of 2026-10-29.
DRUG's 14-day RSI is 53.9, in neutral territory. At $56.69 it is trading 22.8% below its 200-day moving average of $73.44, and below its 50-day average of $59.65. Price sits above the upper Bollinger Band ($48.36 to $56.65). ADX reads 23.4, sitting between trending and range-bound.
Overview
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Finance Bot
Ask your questions
Start by typing a question below.
